Greenwich LifeSciences (GLSI) Change in Cash (2019 - 2025)
Greenwich LifeSciences (GLSI) posted Change in Cash of $2.4 million for Q4 2025, up 247.72% on a QoQ basis from $681877.0 in Q3 2025, and up 237.02% year-over-year from $703522.1 in Q4 2024.
Greenwich LifeSciences (GLSI) Change in Cash (2019 - 2025) Analysis & Trends
Greenwich LifeSciences' Change in Cash history runs 7 years deep, the most recent figure standing at $2.4 million for Q4 2025.
- Quarterly Change in Cash rose 237.02% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 million (up 172.0% YoY) and the FY2025 annual result came in at $2.1 million, up 172.0% from the prior year.
- Change in Cash was $2.4 million for Q4 2025 at Greenwich LifeSciences, up from $681877.0 in the prior quarter.
- Across five years, Change in Cash topped out at $2.4 million in Q4 2025 and bottomed at -$7.5 million in Q1 2022.
- A 5-year average of -$1.1 million and a median of -$1.4 million in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash tumbled 527.68% — and 2024, when it jumped 277.76%.
- Greenwich LifeSciences' Change in Cash stood at -$1.7 million in 2021, then retreated by 27.52% to -$2.2 million in 2022, then climbed by 0.73% to -$2.2 million in 2023, then increased by 19.67% to -$1.7 million in 2024, then soared by 237.02% to $2.4 million in 2025.
- Business Quant data shows GLSI's Change in Cash at $2.4 million in Q4 2025, $681877.0 in Q3 2025, and $375142.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Greenwich LifeSciences | 178.53 Mn | 178.53 Mn | - | 2.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.37 Mn |
| Sep 30, 2025 | 681,877.00 |
| Jun 30, 2025 | 375,142.00 |
| Mar 31, 2025 | -1.34 Mn |
| Dec 31, 2024 | -1.73 Mn |
| Sep 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | -1.48 Mn |
| Dec 31, 2023 | -2.15 Mn |
| Sep 30, 2023 | -1.80 Mn |
| Jun 30, 2023 | -966,977.00 |
| Mar 31, 2023 | -1.56 Mn |
| Dec 31, 2022 | -2.17 Mn |
| Sep 30, 2022 | -1.55 Mn |
| Jun 30, 2022 | -2.56 Mn |
| Mar 31, 2022 | -7.46 Mn |
| Dec 31, 2021 | -1.70 Mn |
| Sep 30, 2021 | -894,639.00 |
| Jun 30, 2021 | -604,319.00 |
| Mar 31, 2021 | 1.74 Mn |